Marshall Wace, LLP Stevanato Group S.P.A. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Marshall Wace, LLP holds 156,147 shares of STVN stock, worth $3.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156,147Holding current value
$3.42 Million% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding STVN
# of Institutions
134Shares Held
58MCall Options Held
2.7KPut Options Held
1K-
Conestoga Capital Advisors, LLC8.08MShares$177 Million2.35% of portfolio
-
Neuberger Berman Group LLC New York, NY4.56MShares$100 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.74MShares$82.1 Million0.05% of portfolio
-
Times Square Capital Management, LLC3.29MShares$72.1 Million1.1% of portfolio
-
Thrivent Financial For Lutherans Minneapolis, MN2.78MShares$61.1 Million0.11% of portfolio
About Stevanato Group S.p.A.
- Ticker STVN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 264,700,000
- Market Cap $5.8B
- Description
- Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...